Quick Answer
VACCINEX, INC. reported Shares Outstanding of 2.68 million shares for fiscal year 2024.
VACCINEX, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 2.68M | +199.9% |
| 2023 | 892,617 | +275.8% |
| 2022 | 237,527 | -99.2% |
| 2021 | 30.80M | +37.6% |
| 2020 | 22.39M | +50.4% |
| 2019 | 14.89M | +29.7% |
| 2018 | 11.48M | +940.8% |
| 2017 | 1.10M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | 2.60M | -46.5% | +64.0% |
| March 31, 2024 | 1.58M | -97.1% | +77.6% |
| December 31, 2023 | 892,617 | -73.2% | -81.6% |
| September 30, 2023 | 4.86M | -88.6% | -92.6% |
| June 30, 2023 | 65.67M | +53.9% | +19.7% |
| March 31, 2023 | 54.86M | +28.6% | +1549.6% |
| December 31, 2022 | 3.33M | -89.2% | -92.2% |
| September 30, 2022 | 42.66M | +38.5% | +0.0% |
- VACCINEX, INC. showed an increase of +199.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2024 period, VACCINEX, INC.’s shares outstanding has grown by 142.8% (from 1.10 million shares to 2.68 million shares).
- The most recent figure is from VACCINEX, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: